CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $33.40 ($300,560)
- 8-K/A Event Exhibits
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Director gave up 901 shares (to pay taxes)
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $34.57 ($70,315)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $35.51 ($319,604)
- 144 Insider Sale of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale VP, Finance (Interim PAO) sold 6,890 shares at $29.29 ($201,808)
- 4 Planned sale SVP, Chief Commercial Officer sold 6,000 shares at $30.00 ($180,000)
Page 4 of 97 · 1,927 filings